🕒 Monday 29 June 2026 Mon, 29 June 2026

IRIS Metals posted a $22.3 million loss for FY26, driven by major impairments on exploration assets and elevated share-based payments. The company pivots away from Edison and Tin Mountain projects, focusing on lithium-rubidium in South Dakota and tungsten in Montana.

Global X Management (AUS) Limited has announced estimated distributions for over 30 ETFs for the period ending 30 June 2026, all eligible for reinvestment via its Distribution Reinvestment Plan (DRP). The announcement outlines key dates for investors to act on their DRP elections and highlights the wide range of income levels across its funds.

Synlait Milk has locked in a NZ$320 million refinancing package with a broad banking syndicate and replaced its $130 million shareholder loan, while shifting its financial year-end to December to match its major shareholder.

The Takeovers Panel has directed Humm Group to cover $44,599.50 of legal costs incurred by Mr Jeremy Raper amid proceedings over shareholder disputes and misleading statements. The payment must be made within 90 days, reflecting the Panel’s finding of procedural delays and compliance failures by Humm.

Autosports Group reports a 22% jump in order write driven by battery electric vehicles, with FY26 profit forecast raised to $51-54 million.

Macarthur Minerals narrowed its loss to $1.82 million for FY26, bolstered by a major new investor and joint venture at its Lake Giles iron ore project in Western Australia.

Sprintex Limited has locked in underwriting agreements covering 8.7 million unexercised options, potentially raising up to A$870,000. The company also agreed to extend a A$1.85 million convertible note maturity by one year, pending shareholder approval.

DevEx Resources has finalised the acquisition of Alligator Energy’s uranium tenements in the Alligator Rivers Uranium Province, expanding its landholding to about 9,200 km² around the historic Nabarlek Mine.

Adherium Limited has obtained a USD 1.65 million short-term unsecured loan from its major shareholder, Trudell Medical, to fund immediate working capital needs while pursuing capital structure adjustments.

ClearVue Technologies is inviting eligible shareholders to participate in a $1 million Share Purchase Plan at a discount, following a $5 million institutional placement. The capital raised will support ERP rollout, R&D, and working capital.

Nimy Resources (ASX: NIM) responds to ASX query following a sharp share price fall, confirming pending assay results from recent sampling but no undisclosed information explaining the trading.

Booster Innovation Fund reported a $1.593 million profit for the year ended March 2026, supported by increased net assets. However, valuation risks persist due to early-stage investments and recent capital raises at lower prices.

Booster Investment Scheme 2's Private Land and Property Fund swung back to profit with NZD 1.3 million after tax for the year ended March 2026, despite net asset value slipping due to unit redemptions. The Fund’s investment portfolio remains concentrated in unlisted New Zealand agricultural and property assets, while its Manager faces unrelated FMA proceedings.

Orbminco Limited's latest infill drilling at Majestic North delivers standout shallow gold grades, setting the stage for a resource upgrade and advancing mining studies.

Manuka Resources has secured the final US$4 million tranche of its US$30 million Nebari facility, fueling its push to restart gold production at Mt Boppy and silver output at Wonawinta by September 2026.

Quantum Graphite and Sunlands Pure have cleared a major regulatory hurdle with environmental approvals for their Al Buraimi graphite refinery in Oman, paving the way for large-scale production of high-purity graphite.

Strategic Energy Resources (ASX:SER) has raised $1.5 million through a discounted share placement and a fully underwritten share purchase plan to back a high-impact drilling campaign at its Diamantina Copper-Gold Project in Queensland.

HITIQ Limited has secured $1.4 million through a private placement of 200 million shares at 0.7 cents each, accompanied by options exercisable until 2029. The capital will bolster its balance sheet and back expansion and commercialisation efforts.

BCAL Diagnostics has locked in an additional $4.9 million under its existing convertible note facility alongside a $1.4 million R&D tax offset tranche, reinforcing its funding runway into FY2027 for early cancer detection test development.

Clarity Pharmaceuticals will present compelling data at EANM 2026 demonstrating its 64Cu-SAR-bisPSMA imaging agent’s superior detection of prostate cancer recurrence and promising therapeutic results from 67Cu-SAR-bisPSMA in advanced disease.

Sunstone Metals secures $10 million in a discounted placement led by DGR Global, which gains a 10% shareholding and board representation to accelerate exploration at high-potential Ecuador projects.

Sunstone Metals has raised $10 million through a discounted share placement, with strategic investor DGR Global acquiring a 10% stake and board representation. The funds will boost exploration and development at Sunstone’s high-potential gold-copper projects in Ecuador.

Infratil Limited has issued nearly 2.8 million new ordinary shares under its Dividend Reinvestment Plan at an issue price of NZD 14.70 each, expanding its capital base without altering shareholder rank.

Lumos Diagnostics has received a A$709,837 cash refund from the Australian Government’s R&D Tax Incentive, bolstering its investment in proprietary point-of-care diagnostic technologies.